Clinical Trial

Russian Registry of Endovascular Closure of PFO

Study acronym: ENDOVAL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The study will include all patients over 18 years of age who underwent endovascular closure of patent foramen ovale in medical centers in the Russian Federation, who gave written informed consent to the closure and provided personal data as part of inpatient medical care. The project participants will be 29 medical centers in the Russian Federation, where endovascular closure of patent foramen ovale is performed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-27.
Status change: Not Yet Recruiting → Recruiting 2025-01-27
Trial Details
NCT Number NCT06156670
Lead Sponsor National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Conditions Patent Foramen Ovale
Enrollment 700 participants
Start Date 2023-12-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-29